vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Huron Consulting Group Inc. (HURN). Click either name above to swap in a different company.
Huron Consulting Group Inc. is the larger business by last-quarter revenue ($442.0M vs $268.1M, roughly 1.6× ACADIA PHARMACEUTICALS INC). Huron Consulting Group Inc. runs the higher net margin — 6.9% vs 1.4%, a 5.6% gap on every dollar of revenue. On growth, Huron Consulting Group Inc. posted the faster year-over-year revenue change (10.7% vs 9.7%). Over the past eight quarters, Huron Consulting Group Inc.'s revenue compounded faster (10.3% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Huron Consulting Group, commonly known as Huron, is a management consulting firm offering services to the healthcare, life sciences, commercial, and higher education industries.
ACAD vs HURN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $442.0M |
| Net Profit | $3.6M | $30.7M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 11.4% |
| Net Margin | 1.4% | 6.9% |
| Revenue YoY | 9.7% | 10.7% |
| Net Profit YoY | — | -9.8% |
| EPS (diluted) | $0.02 | $1.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | — | ||
| Q4 25 | $284.0M | $442.0M | ||
| Q3 25 | $278.6M | $441.3M | ||
| Q2 25 | $264.6M | $411.8M | ||
| Q1 25 | $244.3M | $404.1M | ||
| Q4 24 | $259.6M | $399.3M | ||
| Q3 24 | $250.4M | $378.1M | ||
| Q2 24 | $242.0M | $381.0M |
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | $30.7M | ||
| Q3 25 | $71.8M | $30.4M | ||
| Q2 25 | $26.7M | $19.4M | ||
| Q1 25 | $19.0M | $24.5M | ||
| Q4 24 | $143.7M | $34.0M | ||
| Q3 24 | $32.8M | $27.1M | ||
| Q2 24 | $33.4M | $37.5M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 11.4% | ||
| Q3 25 | 12.8% | 11.3% | ||
| Q2 25 | 12.2% | 11.1% | ||
| Q1 25 | 7.9% | 8.1% | ||
| Q4 24 | 59.1% | 11.8% | ||
| Q3 24 | 12.6% | 11.2% | ||
| Q2 24 | 12.6% | 15.6% |
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | 6.9% | ||
| Q3 25 | 25.8% | 6.9% | ||
| Q2 25 | 10.1% | 4.7% | ||
| Q1 25 | 7.8% | 6.1% | ||
| Q4 24 | 55.4% | 8.5% | ||
| Q3 24 | 13.1% | 7.2% | ||
| Q2 24 | 13.8% | 9.8% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $1.71 | ||
| Q3 25 | $0.42 | $1.71 | ||
| Q2 25 | $0.16 | $1.09 | ||
| Q1 25 | $0.11 | $1.33 | ||
| Q4 24 | $0.86 | $1.82 | ||
| Q3 24 | $0.20 | $1.47 | ||
| Q2 24 | $0.20 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $24.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $528.6M |
| Total Assets | $1.6B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | $24.5M | ||
| Q3 25 | $258.0M | $23.9M | ||
| Q2 25 | $253.6M | $61.0M | ||
| Q1 25 | $217.7M | $23.4M | ||
| Q4 24 | $319.6M | $21.9M | ||
| Q3 24 | $155.1M | $18.5M | ||
| Q2 24 | $177.1M | $17.6M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $528.6M | ||
| Q3 25 | $917.3M | $499.8M | ||
| Q2 25 | $822.4M | $475.0M | ||
| Q1 25 | $765.2M | $494.3M | ||
| Q4 24 | $732.8M | $561.3M | ||
| Q3 24 | $577.2M | $522.8M | ||
| Q2 24 | $516.7M | $500.6M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $976.9M | $1.3B | ||
| Q2 24 | $914.1M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $126.4M |
| Free Cash FlowOCF − Capex | — | $123.8M |
| FCF MarginFCF / Revenue | — | 28.0% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $183.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $126.4M | ||
| Q3 25 | $74.3M | $93.8M | ||
| Q2 25 | $64.0M | $80.0M | ||
| Q1 25 | $20.3M | $-106.8M | ||
| Q4 24 | $40.4M | $139.6M | ||
| Q3 24 | $63.2M | $85.2M | ||
| Q2 24 | $25.0M | $107.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $123.8M | ||
| Q3 25 | $73.9M | $89.8M | ||
| Q2 25 | — | $78.0M | ||
| Q1 25 | — | $-108.7M | ||
| Q4 24 | — | $137.0M | ||
| Q3 24 | $63.2M | $82.8M | ||
| Q2 24 | — | $104.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 28.0% | ||
| Q3 25 | 26.5% | 20.3% | ||
| Q2 25 | — | 18.9% | ||
| Q1 25 | — | -26.9% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | 25.2% | 21.9% | ||
| Q2 24 | — | 27.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | — | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 4.12× | ||
| Q3 25 | 1.03× | 3.08× | ||
| Q2 25 | 2.40× | 4.12× | ||
| Q1 25 | 1.07× | -4.35× | ||
| Q4 24 | 0.28× | 4.11× | ||
| Q3 24 | 1.93× | 3.14× | ||
| Q2 24 | 0.75× | 2.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
HURN
| Consulting And Managed Services Capability | $172.9M | 39% |
| Education | $118.7M | 27% |
| Commercial | $91.9M | 21% |
| Digital Capability | $54.6M | 12% |
